Clinical Trial Update: Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II) [Phase 4]

View source ↗

Summary

Phase 4 trial update for zoledronic acid evaluating prevention of osteoporotic fractures in postmenopausal osteoporosis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis in Postmenopausal Women
• Osteoporotic Fractures

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Susan L. Greenspan | Conditions: Osteoporotic Fractures, Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED | Results posted: 2023-08-16